John Duffy
Psychiatry · Santa Ana, CANPI 1255497251
Payments from drug & device makers
Across 643 payments — averaging $18,674 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$5.1M
- Biogen$2.1M
- Eisai Inc.$1.1M
- AbbVie$757K
- UCB SA$643K
- Genentech, Inc.$464K
- plus $1.8M from 13 others
Across 14 payments — averaging $2088.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$27K
- Eisai Inc.$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 70 | $5,118,327 |
| Biogen | 16 | $2,111,016 |
| Eisai Inc. | 100 | $1,141,814 |
| AbbVie(2 entities) | 65 | $757,012 |
| UCB SA | 6 | $642,828 |
| Genentech, Inc. | 41 | $463,965 |
| Janssen Research & Development, LLC | 104 | $446,027 |
| Novartis | 4 | $357,884 |
| Acadia Pharmaceuticals Inc | 56 | $353,894 |
| E.r. Squibb & Sons, L.L.C. | 4 | $218,225 |
| Novo Nordisk AS | 51 | $168,901 |
| Livanova USA, Inc. | 53 | $76,745 |
| Neurocrine Biosciences, Inc. | 54 | $71,895 |
| Avanir Pharmaceuticals, Inc. | 11 | $62,825 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $11,100 |
| Sunovion Pharmaceuticals Inc. | 2 | $2,550 |
| GRT US Holding, Inc. | 2 | $2,218 |
| Novo Nordisk | 1 | $125 |
| F. Hoffmann-la Roche AG | 1 | $80 |
How this compares
$12,007,431 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Santa Ana
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
- Gustavo AlvaOrange$9.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.